|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/18 | |
| A61K 38/19 | |||
| A61K 38/20 | |||
| A61K 38/21 | |||
| A61F 2/16 | |||
| A61K 9/00 | |||
| A61K 35/30 | |||
| A61P 27/02 | |||
| A61P 27/06 |
| (11) | Patento numeris | 3302524 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16729691.2 |
| Europos patento paraiškos padavimo data | 2016-05-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/034552 |
| Data | 2016-05-27 |
| (87) | Numeris | WO 2016/191645 |
| Data | 2016-12-01 |
| (30) | Numeris | Data | Šalis |
| 201562167213 P | 2015-05-27 | US |
| (72) |
GOLDBERG, Jeffrey, Louis, US
MCGOVERN, Cahil, US
TAO, Weng, US
KAUPER, Konrad, US
|
| (73) |
Neurotech USA, Inc.,
900 Highland Corporate Drive Building No. 1 Suite No. 101, Cumberland, RI 02864,
US
|
| (54) | USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF GLAUCOMA |
| USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF GLAUCOMA |